265 related articles for article (PubMed ID: 24337823)
1. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.
Behrens-Gawlik V; Mearini G; Gedicke-Hornung C; Richard P; Carrier L
Pflugers Arch; 2014 Feb; 466(2):215-23. PubMed ID: 24337823
[TBL] [Abstract][Full Text] [Related]
2. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.
Tudurachi BS; Zăvoi A; Leonte A; Țăpoi L; Ureche C; Bîrgoan SG; Chiuariu T; Anghel L; Radu R; Sascău RA; Stătescu C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445689
[TBL] [Abstract][Full Text] [Related]
3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
4. MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.
Kuster DW; Sadayappan S
Pflugers Arch; 2014 Feb; 466(2):207-13. PubMed ID: 24327208
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
7. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
Parbhudayal RY; Garra AR; Götte MJW; Michels M; Pei J; Harakalova M; Asselbergs FW; van Rossum AC; van der Velden J; Kuster DWD
J Mol Cell Cardiol; 2018 Oct; 123():59-63. PubMed ID: 30170119
[TBL] [Abstract][Full Text] [Related]
8. Targeting the population for gene therapy with MYBPC3.
Carrier L
J Mol Cell Cardiol; 2021 Jan; 150():101-108. PubMed ID: 33049255
[TBL] [Abstract][Full Text] [Related]
9. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy strategies in the treatment of hypertrophic cardiomyopathy.
Prondzynski M; Mearini G; Carrier L
Pflugers Arch; 2019 May; 471(5):807-815. PubMed ID: 29971600
[TBL] [Abstract][Full Text] [Related]
11. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
Suay-Corredera C; Pricolo MR; Herrero-Galán E; Velázquez-Carreras D; Sánchez-Ortiz D; García-Giustiniani D; Delgado J; Galano-Frutos JJ; García-Cebollada H; Vilches S; Domínguez F; Molina MS; Barriales-Villa R; Frisso G; Sancho J; Serrano L; García-Pavía P; Monserrat L; Alegre-Cebollada J
J Biol Chem; 2021 Jul; 297(1):100854. PubMed ID: 34097875
[TBL] [Abstract][Full Text] [Related]
12. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
[TBL] [Abstract][Full Text] [Related]
13. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.
Barefield D; Kumar M; Gorham J; Seidman JG; Seidman CE; de Tombe PP; Sadayappan S
J Mol Cell Cardiol; 2015 Feb; 79():234-43. PubMed ID: 25463273
[TBL] [Abstract][Full Text] [Related]
15. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
[TBL] [Abstract][Full Text] [Related]
16. Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice.
Gedicke-Hornung C; Behrens-Gawlik V; Reischmann S; Geertz B; Stimpel D; Weinberger F; Schlossarek S; Précigout G; Braren I; Eschenhagen T; Mearini G; Lorain S; Voit T; Dreyfus PA; Garcia L; Carrier L
EMBO Mol Med; 2013 Jul; 5(7):1128-45. PubMed ID: 23716398
[TBL] [Abstract][Full Text] [Related]
17. The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP-C.
Suay-Corredera C; Alegre-Cebollada J
FEBS Lett; 2022 Mar; 596(6):703-746. PubMed ID: 35224729
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
19. Activation of Autophagy Ameliorates Cardiomyopathy in
Singh SR; Zech ATL; Geertz B; Reischmann-Düsener S; Osinska H; Prondzynski M; Krämer E; Meng Q; Redwood C; van der Velden J; Robbins J; Schlossarek S; Carrier L
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021349
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model.
Da'as SI; Yalcin HC; Nasrallah GK; Mohamed IA; Nomikos M; Yacoub MH; Fakhro KA
J Cell Physiol; 2020 Nov; 235(11):7870-7888. PubMed ID: 31943169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
